Publication Misconduct:
To uphold the standards of academic publishing, the Pakistan Journal of Pharmaceutical Sciences (PJPS) efforts its level best to ensure the high standards of publication ethics and follows ICMJE ICMJE Guidelines. Publication Misconduct refers to inappropriate or unacceptable behavior in publishing articles. It can include plagiarism, fabrication, falsification, inappropriate authorship, duplicate submissions, overlapping publication, and salami publication. PJPS takes all the necessary actions to protect the integrity of original data.
Plagiarism:
Plagiarism is an unauthorized use of another person's words, ideas, data, statistics, images, research techniques, or other materials (conference proceedings, seminar presentation, project reports, dissertation, research proposal/synopsis, published/unpublished data, grey literature etc.), without giving due acknowledgment.
Policy of the Journal:
• The Journal uses Turnitin for Plagiarism checking, once an article is submitted. The plagiarism report of 19% and below is acceptable.
• Articles having Plagiarism above 19% will be rejected.
• The journal discourages excessive self-citations by authors too.
Fabrication:
Fabrication refers to the act of creating data or outcomes without conducting the necessary investigation.
Policy of the Journal
• Retraction of the paper is to be done by the Author once the data fabrication has been proven.
• The Journal encourages data repositories to ensure data is not fabricated.
• To assist the Journal with manuscript evaluation, authors are expected to retain all raw data represented in their manuscripts.
• If the original data cannot be produced on request, acceptance of a manuscript or published paper may be declined.
Falsification:
The deliberate manipulation of data or outcomes to lead to an inaccurate conclusion is known as falsification.
Policy of the Journal
• The journal may ask for the rejection of manuscript or ask the author for a withdrawal.
• If falsification of data is proved the journal will not accept the manuscripts of the same author for a year.
Inappropriate Authorship: According to the author's actual contributions, authorship is not accurately ascribed.
Policy of the Journal • Removal of the name of the author that doesn’t line up with the author’s contribution criteria of the Journal.
Duplicate Submissions The practice of submitting the same manuscript, or multiple manuscripts with slight variations (such as differences in the title, keywords, abstract, author order, author affiliations, or a small amount of text), to two or more journals simultaneously, or submitting to another journal within a predetermined window of time, is known as duplicate submission or multiple submissions.
Policy of the Journal
• Rejection of the Manuscript.
• Inform the Journal in which the article has been published about the author's Duplicate Submission.
• Inform the Author’s affiliated Institute about his/her misconduct.
Overlapping Publication: The act of publishing a paper that considerably overlaps with one that has previously been published is known as "overlapping publication."
Policy of the Journal • Withdrawal of the article by the author/ Rejection of the manuscript.
Salami Publication: The term "salami publication" describes the process of publishing data from two or more studies that address the same population, techniques, and questions after dividing a major study's data into separate portions that could have been presented in a single paper.
Policy of the Journal Policy of the Journal
Image Manipulation: When a conscious effort has been made to incorrectly alter or create a picture. This is a significant form of misconduct since it is intended to deceive people and compromise the credibility of academic research, both of which have far-reaching and permanent repercussions.
Policy of the Journal
• Pakistan Journal of Pharmaceutical Sciences expects that all of the photos in the manuscripts be authentic and unaltered.
• It is forbidden to improve, hide, relocate, eliminate, or add specific characteristics from an image without providing sufficient notice of the change.
• Images may be altered in terms of brightness, contrast, or color balance as long as the original information is not lost, obscured, or misrepresented.
• It is necessary to explicitly state whether or not to group images from various gel sections, western blots, or microscope images in the figure arrangement or figure legend language.
• It is necessary to explicitly state whether or not to group images from various gel sections, western blots, or microscope images in the figure arrangement or figure legend language.
